Nemus Bioscience Inc. (NMUS) Attends 31st Annual ROTH Conference
Nemus Bioscience (OTCQB: NMUS) is a biopharmaceutical company focused on the discovery, development and commercialization of bioengineered cannabinoid-based therapeutics for significant unmet medical needs. With proprietary technology licensed from the University of Mississippi, Nemus is developing novel ways to deliver cannabinoid-based drugs for specific indications with the aim of optimizing the clinical effects of such drugs while limiting potential adverse events. Nemus' strategy is to explore the use of proprietary biosynthetic compounds, alone or in combination with corporate partners. The company is led by a highly qualified team of executives with decades of biopharmaceutical experience and a significant background in…







